Greater Cannabis Company (GCAN) Depreciation & Amortization (CF) (2020 - 2023)
Greater Cannabis Company's (GCAN) quarterly Depreciation & Amortization (CF) came in at $1250.0 in Q4 2023, little changed year-on-year from $1250.0 in Q4 2022, and little changed quarter-over-quarter from $1250.0 in Q3 2023.
Greater Cannabis Company (GCAN) Depreciation & Amortization (CF) (2020 - 2023) Analysis & Trends
Greater Cannabis Company's Depreciation & Amortization (CF) history runs 4 years deep, the most recent figure standing at $1250.0 for Q4 2023.
- On a quarterly basis, Depreciation & Amortization (CF) changed 0.0% year-over-year to $1250.0 in Q4 2023; TTM through Sep 2024 was $1250.0, a 75.0% decrease from a year earlier, with the FY2023 full-year figure at $5000.0, changed 0.0% from the prior year.
- Depreciation & Amortization (CF) steadied at $1250.0 in Q4 2023 per GCAN's latest filing, from $1250.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $1250.0 in Q2 2020 and bottomed at $833.0 in Q1 2020.
- The 4-year median for Depreciation & Amortization (CF) is $1250.0 (2020), against an average of $1223.9.
- Biggest YoY gain for Depreciation & Amortization (CF) was 50.06% in 2021; the steepest drop was 0.0% in 2021.
- Year by year, Depreciation & Amortization (CF) stood at $1250.0 in 2020, then changed by 0.0% to $1250.0 in 2021, then changed by 0.0% to $1250.0 in 2022, then changed by 0.0% to $1250.0 in 2023.
- Per Business Quant, the three latest GCAN Depreciation & Amortization (CF) figures stand at $1250.0 (Q4 2023), $1250.0 (Q3 2023), and $1250.0 (Q2 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 239.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.04 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 22.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 676.10 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 7.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 172.00 Mn |
| 10 | Greater Cannabis Company | 292,929.85 | 292,929.85 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 1,250.00 |
| Dec 31, 2023 | 1,250.00 |
| Sep 30, 2023 | 1,250.00 |
| Sep 30, 2023 | 1,250.00 |
| Jun 30, 2023 | 1,250.00 |
| Jun 30, 2023 | 1,250.00 |
| Mar 31, 2023 | 1,250.00 |
| Mar 31, 2023 | 1,250.00 |
| Dec 31, 2022 | 1,250.00 |
| Dec 31, 2022 | 1,250.00 |
| Sep 30, 2022 | 1,250.00 |
| Sep 30, 2022 | 1,250.00 |
| Jun 30, 2022 | 1,250.00 |
| Jun 30, 2022 | 1,250.00 |
| Mar 31, 2022 | 1,250.00 |
| Mar 31, 2022 | 1,250.00 |
| Dec 31, 2021 | 1,250.00 |
| Dec 31, 2021 | 1,250.00 |
| Sep 30, 2021 | 1,250.00 |
| Sep 30, 2021 | 1,250.00 |